Cargando…
Erratum to: Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557853/ https://www.ncbi.nlm.nih.gov/pubmed/26330228 http://dx.doi.org/10.1186/s13075-015-0752-9 |
_version_ | 1782388530096373760 |
---|---|
author | Singh, Jasvinder A. Akhras, Kasem S. Shiozawa, Aki |
author_facet | Singh, Jasvinder A. Akhras, Kasem S. Shiozawa, Aki |
author_sort | Singh, Jasvinder A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4557853 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45578532015-09-03 Erratum to: Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort Singh, Jasvinder A. Akhras, Kasem S. Shiozawa, Aki Arthritis Res Ther Erratum BioMed Central 2015-09-02 2015 /pmc/articles/PMC4557853/ /pubmed/26330228 http://dx.doi.org/10.1186/s13075-015-0752-9 Text en © Singh et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Erratum Singh, Jasvinder A. Akhras, Kasem S. Shiozawa, Aki Erratum to: Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort |
title | Erratum to: Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort |
title_full | Erratum to: Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort |
title_fullStr | Erratum to: Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort |
title_full_unstemmed | Erratum to: Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort |
title_short | Erratum to: Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort |
title_sort | erratum to: comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large u.s. managed care cohort |
topic | Erratum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557853/ https://www.ncbi.nlm.nih.gov/pubmed/26330228 http://dx.doi.org/10.1186/s13075-015-0752-9 |
work_keys_str_mv | AT singhjasvindera erratumtocomparativeeffectivenessofurateloweringwithfebuxostatversusallopurinolingoutanalysesfromlargeusmanagedcarecohort AT akhraskasems erratumtocomparativeeffectivenessofurateloweringwithfebuxostatversusallopurinolingoutanalysesfromlargeusmanagedcarecohort AT shiozawaaki erratumtocomparativeeffectivenessofurateloweringwithfebuxostatversusallopurinolingoutanalysesfromlargeusmanagedcarecohort |